Blindsight will enable those who have total loss of vision… to be able to see again,” tweeted Elon Musk. That’s not the kind ...

Cortigent is a leading developer of brain interface devices based on precision neurostimulation technology The company’s new ...

Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology Cortigent is the only company to have obtained FDA approval of a device providing artificial ...

Building on decades of experience in serving embedded applications where low power, affordability and ease of development are critical, Microchip Technology ...

Neuralink nears human trials for Blindsight, a revolutionary brain implant promising to restore sight to the blind. Learn how ...

Vivani Medical subsidiary Cortigent announced the results of a study evaluating its Orion visual cortical prosthesis system.

Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology Cortigent is the ...

Building on decades of experience in serving embedded applications where low power, affordability and ease of development are ...

Neuralink is preparing to begin its first human clinical trials of the Blindsight implant in 2026, which aims to restore vision for people with complete blindness.Neuralink Founder Elon Musk ...

We'e rapidly entering an era where robots don;t simply operate with human commands from static maps and point-to-point instructions; they do so autonomously — and with each other.

AgentStack targets the biggest blocker in enterprise AI, operationalizing multi‑agent systems without locking developers into ...

The human brain's soft folds and ridges, arising in early development and continuing through the first 18 months of life, are ...